Brexit Could Quell UK’s Voice In EU Medtech Regs Debate
This article was originally published in Clinica
The UK has always been a highly active authority in leading discussions and initiating action in the EU medtech regulatory space. Arguably, along with France, it has been the most active among its other EU counterparts. So what will the UK’s influence be if it votes to leave the EU during the June 23 referendum and would the EU’s medtech rules still apply? Clinica’s Amanda Maxwell sought the opinions of Alexander Denoon and Erik Vollebregt.